Please login to the form below

Not currently logged in

PatientsLikeMe names Jason Johnson as head of R&D

Will also be an executive vice president

jason johnson patientslikemePatientsLikeMe has appointed Jason Johnson as executive vice president and head of research and development (R&D).

Johnson will lead the company's research, data science and informatics teams, which focus on analysing and merging patient-reported data and other data types to develop models of disease progression and generate new insights about disease, treatments and health.

Commenting on his appointment, Johnson said: “PatientsLikeMe's ability to bring patients together to share data and insights can transform the way healthcare is practiced and substantially increase value to patients.

“I'm excited to be working on healthcare informatics from the perspective of the patient. I believe that amassing and analysing relevant health and medical information from many people with similar experiences and patterns of data can deliver research insights that improve healthcare decision making and patient health.”

Johnson joins from Merck where he held varying roles, most recently as associate vice president for scientific informatics where he helped build the company's informatics and analytics capabilities and was additionally responsible for applied maths and modelling, scientific computing and research software engineering. 

He has also held roles at Rosetta Inpharmatics, a Seattle, US, based biotech, and at Pfizer.

Martin Coulter, CEO at PatientsLikeMe, said: “Our research and informatics teams bring the data to life by extracting insight and meaning about the patient experience, and helping our partners see which medicines and therapeutic approaches will benefit patients the most. 

The combination of Jason's leadership and our scientifically-validated data will be a powerful source of insight to guide discovery, development, and treatment decision making.”

26th May 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....